Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification

Ishwarial Jialal, Scott M Grundy

Research output: Contribution to journalArticle

182 Citations (Scopus)

Abstract

Several lines of evidence indicate that the oxidative modification of low density lipoproteins (LDL) may provide an important link between plasma LDL and the genesis of the atherosclerotic lesion. Ascorbate is an important water-soluble, chain-breaking antioxidant in humans. Probucol, a lipid-soluble antioxidant drug has been shown to retard the progression of atherosclerosis. The aim of the present study was to compare the effects of probucol and physiologic levels of ascorbate on the oxidative modification of LDL in both a cell-free (2.5 μM Cu++ in phosphate-buffered saline) and cellular system (human monocyte macrophages in Ham's F-10 medium). Both ascorbate and probucol inhibited the oxidative modification of LDL in both systems to a similar degree as evidenced by the thiobarbituric acid-reacting substance activity, electrophoretic mobility, and degradation by macrophages. However, whereas co-incubation with physiologic levels of ascorbate resulted in a substantial preservation of the α-tocopherol, γ-tocopherol, and β-carotene of the LDL, probucol in concentrations ranging from 10 to 80 μM failed to protect these antioxidants. Thus, in addition to being as potent as probucol in inhibiting the oxidation of LDL, ascorbate in contrast preserves the endogenous antioxidants in the LDL.

Original languageEnglish (US)
Pages (from-to)597-601
Number of pages5
JournalJournal of Clinical Investigation
Volume87
Issue number2
StatePublished - 1991

Fingerprint

Probucol
LDL Lipoproteins
Antioxidants
Tocopherols
Macrophages
Carotenoids
Monocytes
Atherosclerosis
Phosphates
Lipids
Water

Keywords

  • Atherosclerosis
  • Lipid peroxidation
  • Lipoproteins
  • Macrophages
  • Scavenger receptor

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{7f128fabe8164c9c8887325d207acb81,
title = "Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification",
abstract = "Several lines of evidence indicate that the oxidative modification of low density lipoproteins (LDL) may provide an important link between plasma LDL and the genesis of the atherosclerotic lesion. Ascorbate is an important water-soluble, chain-breaking antioxidant in humans. Probucol, a lipid-soluble antioxidant drug has been shown to retard the progression of atherosclerosis. The aim of the present study was to compare the effects of probucol and physiologic levels of ascorbate on the oxidative modification of LDL in both a cell-free (2.5 μM Cu++ in phosphate-buffered saline) and cellular system (human monocyte macrophages in Ham's F-10 medium). Both ascorbate and probucol inhibited the oxidative modification of LDL in both systems to a similar degree as evidenced by the thiobarbituric acid-reacting substance activity, electrophoretic mobility, and degradation by macrophages. However, whereas co-incubation with physiologic levels of ascorbate resulted in a substantial preservation of the α-tocopherol, γ-tocopherol, and β-carotene of the LDL, probucol in concentrations ranging from 10 to 80 μM failed to protect these antioxidants. Thus, in addition to being as potent as probucol in inhibiting the oxidation of LDL, ascorbate in contrast preserves the endogenous antioxidants in the LDL.",
keywords = "Atherosclerosis, Lipid peroxidation, Lipoproteins, Macrophages, Scavenger receptor",
author = "Ishwarial Jialal and Grundy, {Scott M}",
year = "1991",
language = "English (US)",
volume = "87",
pages = "597--601",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification

AU - Jialal, Ishwarial

AU - Grundy, Scott M

PY - 1991

Y1 - 1991

N2 - Several lines of evidence indicate that the oxidative modification of low density lipoproteins (LDL) may provide an important link between plasma LDL and the genesis of the atherosclerotic lesion. Ascorbate is an important water-soluble, chain-breaking antioxidant in humans. Probucol, a lipid-soluble antioxidant drug has been shown to retard the progression of atherosclerosis. The aim of the present study was to compare the effects of probucol and physiologic levels of ascorbate on the oxidative modification of LDL in both a cell-free (2.5 μM Cu++ in phosphate-buffered saline) and cellular system (human monocyte macrophages in Ham's F-10 medium). Both ascorbate and probucol inhibited the oxidative modification of LDL in both systems to a similar degree as evidenced by the thiobarbituric acid-reacting substance activity, electrophoretic mobility, and degradation by macrophages. However, whereas co-incubation with physiologic levels of ascorbate resulted in a substantial preservation of the α-tocopherol, γ-tocopherol, and β-carotene of the LDL, probucol in concentrations ranging from 10 to 80 μM failed to protect these antioxidants. Thus, in addition to being as potent as probucol in inhibiting the oxidation of LDL, ascorbate in contrast preserves the endogenous antioxidants in the LDL.

AB - Several lines of evidence indicate that the oxidative modification of low density lipoproteins (LDL) may provide an important link between plasma LDL and the genesis of the atherosclerotic lesion. Ascorbate is an important water-soluble, chain-breaking antioxidant in humans. Probucol, a lipid-soluble antioxidant drug has been shown to retard the progression of atherosclerosis. The aim of the present study was to compare the effects of probucol and physiologic levels of ascorbate on the oxidative modification of LDL in both a cell-free (2.5 μM Cu++ in phosphate-buffered saline) and cellular system (human monocyte macrophages in Ham's F-10 medium). Both ascorbate and probucol inhibited the oxidative modification of LDL in both systems to a similar degree as evidenced by the thiobarbituric acid-reacting substance activity, electrophoretic mobility, and degradation by macrophages. However, whereas co-incubation with physiologic levels of ascorbate resulted in a substantial preservation of the α-tocopherol, γ-tocopherol, and β-carotene of the LDL, probucol in concentrations ranging from 10 to 80 μM failed to protect these antioxidants. Thus, in addition to being as potent as probucol in inhibiting the oxidation of LDL, ascorbate in contrast preserves the endogenous antioxidants in the LDL.

KW - Atherosclerosis

KW - Lipid peroxidation

KW - Lipoproteins

KW - Macrophages

KW - Scavenger receptor

UR - http://www.scopus.com/inward/record.url?scp=0026090540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026090540&partnerID=8YFLogxK

M3 - Article

VL - 87

SP - 597

EP - 601

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -